Relationship of Metabolic Syndrome and Its Components With Thyroid Nodule(s)
Primary Purpose
Metabolic Syndrome, Thyroid Nodule
Status
Unknown status
Phase
Locations
Study Type
Observational
Intervention
Sponsored by
About this trial
This is an observational trial for Metabolic Syndrome focused on measuring blood pressure, fasting plasma glucose, thyroid stimulating hormone
Eligibility Criteria
Inclusion Criteria:
- People who received routain physical and laboratory examinations in the Health Management Cenre of QianFoShan Hospital from Jan. 2013 to Dec. 2015.
- signed the informed consent.
- Have complete clinical data.
Exclusion Criteria:
- Patients with previous history of thyroid disease other than thyroid nodules.
- People with abnormal thyroid function.
- Thyroid ultrasound revealed patients with other lesions other than normal thyroid and thyroid nodules.
- Pregnant or lactating women.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Arm Label
The MS group
The non-MS group
Arm Description
Patients with metabolic syndrome(MS).
Patients without metabolic syndrome(MS).
Outcomes
Primary Outcome Measures
The laboratory examinations
Lipids,glucose,thyroid functions
Secondary Outcome Measures
Blood pressure of patients in each group
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03009279
Brief Title
Relationship of Metabolic Syndrome and Its Components With Thyroid Nodule(s)
Official Title
Relationship of Metabolic Syndrome and Its Components With Thyroid Nodule(s)
Study Type
Observational
2. Study Status
Record Verification Date
January 2017
Overall Recruitment Status
Unknown status
Study Start Date
January 2017 (undefined)
Primary Completion Date
November 2017 (Anticipated)
Study Completion Date
December 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Lin Liao
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
To investigate the association between metabolic syndrome (MS) and thyroid nodule(s).
Detailed Description
To investigate the association between metabolic syndrome (MS), body mass index (BMI), hyperglycemia, dyslipidemia, hypertension and thyroid nodule(s) or thyroid functions in euthyroid subjects. Screen for the risk factors that affect the incidence of thyroid nodule(s).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Metabolic Syndrome, Thyroid Nodule
Keywords
blood pressure, fasting plasma glucose, thyroid stimulating hormone
7. Study Design
Enrollment
10000 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
The MS group
Arm Description
Patients with metabolic syndrome(MS).
Arm Title
The non-MS group
Arm Description
Patients without metabolic syndrome(MS).
Primary Outcome Measure Information:
Title
The laboratory examinations
Description
Lipids,glucose,thyroid functions
Time Frame
In 2013-2015
Secondary Outcome Measure Information:
Title
Blood pressure of patients in each group
Time Frame
In 2013-2015
Other Pre-specified Outcome Measures:
Title
BMI of patients in each group
Description
body mass index(BMI)
Time Frame
In 2013-2015
Title
Age of patients in each group
Time Frame
In 2013-2015
Title
Gender of patients in each group
Time Frame
In 2013-2015
10. Eligibility
Sex
All
Minimum Age & Unit of Time
15 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
People who received routain physical and laboratory examinations in the Health Management Cenre of QianFoShan Hospital from Jan. 2013 to Dec. 2015.
signed the informed consent.
Have complete clinical data.
Exclusion Criteria:
Patients with previous history of thyroid disease other than thyroid nodules.
People with abnormal thyroid function.
Thyroid ultrasound revealed patients with other lesions other than normal thyroid and thyroid nodules.
Pregnant or lactating women.
Study Population Description
People who received routain physical and laboratory examinations in the Health Management Cenre of QianFoShan Hospital from Jan. 2013 to Dec. 2015.
Sampling Method
Non-Probability Sample
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lin Liao, MD
Phone
8615168888260
Email
liaolin@medmail.com.cn
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lin Liao
Organizational Affiliation
Qianfoshan Hospital
Official's Role
Study Chair
12. IPD Sharing Statement
Plan to Share IPD
Yes
Learn more about this trial
Relationship of Metabolic Syndrome and Its Components With Thyroid Nodule(s)
We'll reach out to this number within 24 hrs